Literature DB >> 25404032

Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.

Elisa Ramos-Sevillano1, Ana Urzainqui2, Susana Campuzano3, Miriam Moscoso4, Fernando González-Camacho5, Mirian Domenech4, Santiago Rodríguez de Córdoba6, Francisco Sánchez-Madrid2, Jeremy S Brown7, Ernesto García4, Jose Yuste8.   

Abstract

The complement system is a key component of the host immune response for the recognition and clearance of Streptococcus pneumoniae. In this study, we demonstrate that the amidase LytA, the main pneumococcal autolysin, inhibits complement-mediated immunity independently of effects on pneumolysin by a complex process of impaired complement activation, increased binding of complement regulators, and direct degradation of complement C3. The use of human sera depleted of either C1q or factor B confirmed that LytA prevented activation of both the classical and alternative pathways, whereas pneumolysin inhibited only the classical pathway. LytA prevented binding of C1q and the acute-phase protein C-reactive protein to S. pneumoniae, thereby reducing activation of the classical pathway on the bacterial surface. In addition, LytA increased recruitment of the complement downregulators C4BP and factor H to the pneumococcal cell wall and directly cleaved C3b and iC3b to generate degradation products. As a consequence, C3b deposition and phagocytosis increased in the absence of LytA and were markedly enhanced for the lytA ply double mutant, confirming that a combination of LytA and Ply is essential for the establishment of pneumococcal pneumonia and sepsis in a murine model of infection. These data demonstrate that LytA has pleiotropic effects on complement activation, a finding which, in combination with the effects of pneumolysin on complement to assist with pneumococcal complement evasion, confirms a major role of both proteins for the full virulence of the microorganism during septicemia.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25404032      PMCID: PMC4294232          DOI: 10.1128/IAI.02811-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Pathogenesis, treatment, and prevention of pneumococcal pneumonia.

Authors:  Tom van der Poll; Steven M Opal
Journal:  Lancet       Date:  2009-10-31       Impact factor: 79.321

2.  The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Authors:  Jose Yuste; Suneeta Khandavilli; Naadir Ansari; Kairya Muttardi; Laura Ismail; C Hyams; Jeffrey Weiser; Timothy Mitchell; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

3.  Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils.

Authors:  Ankur B Dalia; Alistair J Standish; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

4.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

5.  Human neutrophils kill Streptococcus pneumoniae via serine proteases.

Authors:  Alistair J Standish; Jeffrey N Weiser
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

6.  Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H.

Authors:  Abiodun D Ogunniyi; Marcin Grabowicz; Layla K Mahdi; Jan Cook; David L Gordon; Tania A Sadlon; James C Paton
Journal:  FASEB J       Date:  2008-10-29       Impact factor: 5.191

Review 7.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

8.  Versatility of the capsular genes during biofilm formation by Streptococcus pneumoniae.

Authors:  Mirian Domenech; Ernesto García; Miriam Moscoso
Journal:  Environ Microbiol       Date:  2009-06-22       Impact factor: 5.491

9.  Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.

Authors:  Katherine E Price; Andrew Camilli
Journal:  J Bacteriol       Date:  2009-01-23       Impact factor: 3.490

10.  Streptococcus pneumoniae autolysis prevents phagocytosis and production of phagocyte-activating cytokines.

Authors:  Anna Martner; Susann Skovbjerg; James C Paton; Agnes E Wold
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

View more
  28 in total

1.  The crystal structure of the major pneumococcal autolysin LytA in complex with a large peptidoglycan fragment reveals the pivotal role of glycans for lytic activity.

Authors:  Tatyana Sandalova; Mijoon Lee; Birgitta Henriques-Normark; Dusan Hesek; Shahriar Mobashery; Peter Mellroth; Adnane Achour
Journal:  Mol Microbiol       Date:  2016-07-05       Impact factor: 3.501

2.  The Transcriptional Regulator CpsY Is Important for Innate Immune Evasion in Streptococcus pyogenes.

Authors:  Luis A Vega; Kayla M Valdes; Ganesh S Sundar; Ashton T Belew; Emrul Islam; Jacob Berge; Patrick Curry; Steven Chen; Najib M El-Sayed; Yoann Le Breton; Kevin S McIver
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

3.  The two-component system VicRK regulates functions associated with Streptococcus mutans resistance to complement immunity.

Authors:  Livia A Alves; Erika N Harth-Chu; Thais H Palma; Rafael N Stipp; Flávia S Mariano; José F Höfling; Jacqueline Abranches; Renata O Mattos-Graner
Journal:  Mol Oral Microbiol       Date:  2017-05-25       Impact factor: 3.563

4.  Molecular Characterization of Predominant Serotypes, Drug Resistance, and Virulence Genes of Streptococcus pneumoniae Isolates From East China.

Authors:  Li-Dan Huang; Mei-Juan Yang; Yan-Ying Huang; Ke-Yi Jiang; Jie Yan; Ai-Hua Sun
Journal:  Front Microbiol       Date:  2022-06-01       Impact factor: 6.064

5.  Minilungs from Human Embryonic Stem Cells to Study the Interaction of Streptococcus pneumoniae with the Respiratory Tract.

Authors:  Julio Sempere; Suélen Andreia Rossi; Irene Chamorro-Herrero; Fernando González-Camacho; María Pilar de Lucas; José María Rojas-Cabañeros; Carlos Pelleschi Taborda; Óscar Zaragoza; José Yuste; Alberto Zambrano
Journal:  Microbiol Spectr       Date:  2022-06-13

6.  Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.

Authors:  Bruno Corsini; Roberto Díez-Martínez; Leire Aguinagalde; Fernando González-Camacho; Esther García-Fernández; Patricia Letrado; Pedro García; Jose Yuste
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 7.  Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections.

Authors:  Janine J Wilden; Jasmin C Jacob; Christina Ehrhardt; Stephan Ludwig; Yvonne Boergeling
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

8.  Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains.

Authors:  Jose Manuel Tirado-Vélez; David Carreño; David Sevillano; Luis Alou; José Yuste; Adela G de la Campa
Journal:  Antibiotics (Basel)       Date:  2021-05-13

9.  Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response.

Authors:  Leire Aguinagalde; Bruno Corsini; Arnau Domenech; Mirian Domenech; Jordi Cámara; Carmen Ardanuy; Ernesto García; Josefina Liñares; Asunción Fenoll; Jose Yuste
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Belén de Andrés; Rafael González-Tajuelo; Mirian Domenech; Fernando González-Camacho; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  PLoS Pathog       Date:  2016-03-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.